![](/img/cover-not-exists.png)
P-460 Results of a phase 2 trial of HGS-ETR1 (agonistic humanmonoclonal antibody to TRAIL receptor 1) in subjects with relapsedlrecurrent non-small cell lung cancer (NSCLC)
Bonomi, P., Greco, F., Crawford, J., Kelly, K., Oh, Y., Klein, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80953-5
Date:
July, 2005
File:
PDF, 150 KB
english, 2005